Main

Sorry, this entry is only available in Kazakh and Russian.

The Research Institute for Biological Safety Problems of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (RIBSP) is recruiting volunteers who will take part in the study of a coronavirus vaccine. The study will be conducted at the clinical base of the National Scientific Center for Phthisiopulmonology. The […]

The World Health Organization (WHO) has officially included our domestic inactivated vaccine, developed by scientists of our Institute, into the list of vaccines approved for clinical trials. Kazakhstan vaccine with inactivated virus is in phase 1/2 of clinical trial. The list of vaccines officially approved for clinical trials by WHO also includes 33 vaccines developed […]

Preclinical studies of the Kazakhstan inactivated COVID-19 vaccine developed by the Research Institute for Biological Safety Problems (RIBSP) of SC MES RK on the basis of the pharmacological testing laboratory of the territorial branch of the National Center for Expertise of Medicines and Medical Devices (NCEM) in Almaty have been completed. According to the ministry, […]

In early June this year, the Prime Minister of the Republic of Kazakhstan Askar Uzakpaevich Mamin visited the RSE ” Research Institute for Biological Safety Problems” of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan on a working visit. One of the instructions of the Prime Minister during […]

At the Scientific Research Institute for Biological Safety Problems of the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (hereinafter – RIBSP), on July 26, 2020, five scientists-developers headed by Director General Zakarya K.D. were vaccinated with QazCovid-in – own inactivated COVID-19 vaccine and the next day after observing […]

On August 03, 2020 Akim of Zhambyl region Saparbayev B.M. accompanied by the Akim of the Kordai region and other representatives of the akimats of the Zhambyl oblast, the Kordai region, «КА-СТРОЙ», «Град-Центр» LLP and others, visited the RSE RIBSP. During the visit, the construction site for the project “Construction of a 60-apartment building for […]

On July 31, 2020, the second Kazakhstan vaccine of the RSE “Research Institute for Biological Safety Problems” of the SC MES RK was successfully registered on the website of the World Health Organization (WHO) as a candidate vaccine. This subunit vaccine, developed on the basis of the surface proteins of the virus, is absolutely harmless […]

On July 28, 2020, within the framework of international cooperation, an online video conference was held between the RSE RIBSP MES RK and the DUKE-NUS School of Medicine (Singapore). The conference was held in the format of consultations and recommendations regarding clinical and preclinical trials of COVID-19 vaccine. The online conference was attended by professors […]

The RSE “Research Institute for Biological Safety Problems” of the SC MES RK (RIBSP), as the main institute for virological and microbiological research, still uses the “gold standard” methods, using which a large number of significant results have been obtained. However, the development of new technologies and methods requires the discovery of a new direction. To solve this problem, […]